PharmaLex will be attending DIA's Pharmacovigilance and Risk Management Strategies Conference in Washington D.C., January 22-24, 2018. If you or anyone on your team is attending, please stop by Booth #30 to meet our company representatives: Wenda Brennan, our head of US Pharmacovigilance, and Dr. Judith K. Jones, Head of Pharmacoepidemiology, former President of The Degge Group, Ltd. and earlier, FDA’s Director, Office of Drug Safety (formerly Division of Drug Experience).
Judith K Jones, MD, PhD,FISPE, President of The Degge Group, Ltd. (a PharmaLex company), spoke at the International Society for Pharmacoepidemiology’s 10th Annual Asian Conference on Pharmacoepidemiology (ACPE) in Brisbane, Australia, October 29-31, 2017. She presented her views on the promise and pitfalls of Big Data on Sunday, October 29.
Degge was a Gold Sponsor (and Exhibitor) for the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 26 – 30, 2017 in Montreal, Canada.Our Poster Presentations:
As of April 24, 2017, The Degge Group, Ltd. has become a member of PharmaLex GmbH (Friedrichsdorf, Germany), an international consortium of small companies similar to Degge but with different areas of scientific expertise and focus in the biopharma industry. We are pleased about joining PharmaLex’s group of companies. The impact of Degge’s joining PharmaLex will primarily be felt in our Research and Regulatory Consulting Divisions, which will be enhanced by additional PharmaLex expertise and services. Read More
Our recent publication: Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations was recently published in Journal of Pain. Coauthors included Shannon M Smith and Judith K Jones, MD, PhD, FISPE.
For scientific support in medico-legal affairs please contact Degge's Senior Legal Services Manager through our online form.